Active monitoring versus an abduction device for treatment of infants with centered dysplastic hips: study protocol

Frederike E C M Mulder1, M Adhiambo Witlox2, Carmen D Dirksen3

  • 1Department of Orthopedic Surgery, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands. fecm.mulder@maastrichtuniversity.nl.

BMC Pediatrics
|April 29, 2023
PubMed

Insights

This study compares active monitoring to abduction treatment for infants with centered Developmental Dysplasia of the Hip (DDH). It assesses cost-effectiveness to improve pediatric orthopedic care.

Area of Science:

  • Pediatric Orthopedics
  • Developmental Dysplasia of the Hip (DDH)
  • Clinical Trials

Background:

  • Developmental Dysplasia of the Hip (DDH) is a common pediatric orthopedic condition affecting 1-3% of newborns.
  • Optimal treatment for centered DDH remains under debate.
  • This study addresses the need for evidence on the (cost-)effectiveness of different management strategies.

Purpose of the Study:

  • To compare the (cost-)effectiveness of active monitoring versus abduction treatment for infants with centered DDH.
  • To evaluate secondary outcomes including complications, time to normalization, and health-related quality of life.
  • To inform current care-as-usual for DDH management.

Main Methods:

  • A multicenter, parallel-group, open-label, non-inferiority randomized controlled trial.
  • 800 infants (aged 10-16 weeks) with centered DDH (Graf IIa-/IIb/IIc) were randomized to active monitoring or abduction treatment.
  • Follow-up until 24 months, with primary outcome of normal hips at 12 months (acetabular index < 25 degrees).

Main Results:

  • Primary outcome: Rate of normal hips at 12 months.
  • Secondary outcomes: Normal hips at 24 months, complications, time to normalization, costs, cost-effectiveness, HRQoL, and parent satisfaction.
  • Analysis of baseline patient characteristics' impact on hip normalization.

Conclusions:

  • Outcomes will guide optimal treatment strategies for centered DDH.
  • This trial aims to enhance care for infants diagnosed with DDH.
  • Evidence generated will support clinical decision-making in pediatric hip dysplasia management.
Abstract

Related Concept Videos